Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: A 12-month randomized controlled study

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 1043-1050

  Flodin, Lena ^a,b   Sääf, Maria ^a   Cederholm, Tommy ^c   Al Ani, Amer N ^a,b   Ackermann, Paul W ^a,b   Samnegård, Eva ^b   Dalen, Nils ^b   Hedström, Margareta ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bisphosphonates; Bone mineral density; Hip fracture; Nutritional supplementation

Indexed keywords

CALCICHEW D3; CALCIFEDIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; FRESUBIN; PARATHYROID HORMONE; RISEDRONIC ACID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CALCIUM INTAKE; VITAMIN; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HIP FRACTURE; HUMAN; HYPERCALCEMIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; POSTOPERATIVE CARE; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; ADMINISTRATION AND DOSAGE; BLOOD; BONE REMODELING; CALCIUM INTAKE; DRUG EFFECTS; HIP FRACTURES; METABOLISM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; DIPHOSPHONATES; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; VITAMIN D; VITAMINS;

EID: 84904070196     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S63987     Document Type: Article

References (24)

1. Bachrach-Lindström MA, Ek AC, Unosson M. Nutritional state and functional capacity among elderly Swedish people with acute hip fracture. Scand J Caring Sci. 2000;14(4):268-274.
2. Bell J, Bauer J, Capra S, Pulle CR. Barriers to nutritional intake in patients with acute hip fracture: time to treat malnutrition as a disease and food as a medicine? Can J Physiol Pharmacol. 2013;91(6): 489-495.
3. Fox KM, Magaziner J, Hawkes WG, et al. Loss of bone density and lean body mass after hip fracture. Osteoporos Int. 2000;11(1):31-35.
4. Hedström M. Hip fracture patients, a group of frail elderly people with low bone mineral density, muscle mass and IGF-I levels. Acta Physiol Scand. 1999;167(4):347-350.
5. Karlsson M, Nilsson JA, Sernbo I, Redlund-Johnell I, Johnell O, Obrant KJ. Changes of bone mineral mass and soft tissue composition after hip fracture. Bone. 1996;18(1):19-22.
6. Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham-New SA. Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr. 2009;90(6):1674-1692.
7. Hannan MT, Tucker KL, Dawson-Hughes B, Cupples LA, Felson DT, Kiel DP. Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000; 15(12):2504-2512.
8. Meng X, Zhu K, Devine A, Kerr DA, Binns CW, Prince RL. A 5-year cohort study of the effects of high protein intake on lean mass and BMC in elderly postmenopausal women. J Bone Miner Res. 2009; 24(11):1827-1834.
9. Schürch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128(10):801-809.
10. McClung MR, Geusens P, Miller PD, et al; Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001; 344(5):333-340.
11. Wells GA, Cranney A, Peterson J, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008;(1):CD001155.
12. Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc. 2004;52(11):1832-1839.
13. Boonen S, Orwoll E, Magaziner J, et al; HORIZON Recurrent Fracture Trial. Once-yearly zoledronic acid in older men compared with women with recent hip fracture. J Am Geriatr Soc. 2011;59(11):2084-2090.
14. Lu Y, Fuerst T, Hui S, Genant HK. Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int. 2001;2(6):438-444.
15. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975; 23(10):433-441.
16. Andridge RR, Little RJ. A Review of Hot Deck Imputation for Survey Non-response. Int Stat Rev. 2010;78(1):40-64.
17. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
18. Berger C, Langsetmo L, Joseph L, et al; CaMos Research Group. Association between change in BMD and fragility fracture in women and men. J Bone Miner Res. 2009;24(2):361-370.
19. Eriksen EF, Lyles KW, Colón-Emeric CS, et al. Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res. 2009;24(7):1308-1313.
20. Burden AM, Paterson JM, Solomon DH, Mamdani M, Juurlink DN, Cadarette SM. Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada. Osteoporos Int. 2012;23(3): 1075-1082.
21. Cotté FE, Fardellone P, Mercier F, Gaudin AF, Roux C. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int. 2010;21(1):145-155.
22. Tengstrand B, Cederholm T, Söderqvist A, Tidermark J. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture. Clin Nutr. 2007;26(4):460-465.
23. DeLappe E, McGreevy C, ni Chadhain N, Grimes H, O'Brien T, Mulkerrin E. Vitamin D insufficiency in older female community-dwelling acute hospital admissions and the response to supplementation. Eur J Clin Nutr. 2006;60(8):1009-1015.
24. Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol. 2012;8(7):379-389.